Deaths and complications associated with the management of acute immune thrombotic thrombocytopenic purpura.
Meaghan CollingLova SunVivek UpadhyayJustine RyuAng LiLynne UhlRichard Max KaufmanChristopher P StowellWalter H DzikRobert S MakarPavan K BendapudiPublished in: Transfusion (2020)
Early identification of patients with iTTP and the rapid initiation of TPE are paramount in preventing mortality. While TPE was associated with a high rate of adverse events, the vast majority were treatable and TPE-related mortality is low.